nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—PGR—polycystic ovary syndrome	0.448	0.55	CbGaD
Drospirenone—AR—polycystic ovary syndrome	0.367	0.45	CbGaD
Drospirenone—PGR—corpus luteum—polycystic ovary syndrome	0.0199	0.223	CbGeAlD
Drospirenone—PGR—ovarian follicle—polycystic ovary syndrome	0.0155	0.174	CbGeAlD
Drospirenone—PTGS2—ovarian follicle—polycystic ovary syndrome	0.00776	0.087	CbGeAlD
Drospirenone—NR3C2—adrenal cortex—polycystic ovary syndrome	0.00185	0.0208	CbGeAlD
Drospirenone—NR3C2—endometrium—polycystic ovary syndrome	0.00165	0.0185	CbGeAlD
Drospirenone—PGR—endometrium—polycystic ovary syndrome	0.00154	0.0172	CbGeAlD
Drospirenone—NR3C2—uterus—polycystic ovary syndrome	0.00152	0.0171	CbGeAlD
Drospirenone—NR3C2—pituitary gland—polycystic ovary syndrome	0.0015	0.0168	CbGeAlD
Drospirenone—NR3C2—adipose tissue—polycystic ovary syndrome	0.00149	0.0167	CbGeAlD
Drospirenone—PGR—uterus—polycystic ovary syndrome	0.00142	0.0159	CbGeAlD
Drospirenone—PGR—pituitary gland—polycystic ovary syndrome	0.00139	0.0156	CbGeAlD
Drospirenone—PGR—adipose tissue—polycystic ovary syndrome	0.00139	0.0155	CbGeAlD
Drospirenone—AR—adrenal cortex—polycystic ovary syndrome	0.00137	0.0154	CbGeAlD
Drospirenone—NR3C2—adrenal gland—polycystic ovary syndrome	0.00134	0.015	CbGeAlD
Drospirenone—NR3C2—female gonad—polycystic ovary syndrome	0.00125	0.014	CbGeAlD
Drospirenone—PGR—adrenal gland—polycystic ovary syndrome	0.00124	0.0139	CbGeAlD
Drospirenone—NR3C2—vagina—polycystic ovary syndrome	0.00124	0.0139	CbGeAlD
Drospirenone—AR—endometrium—polycystic ovary syndrome	0.00122	0.0137	CbGeAlD
Drospirenone—NR3C2—endocrine gland—polycystic ovary syndrome	0.00116	0.013	CbGeAlD
Drospirenone—PGR—female gonad—polycystic ovary syndrome	0.00116	0.013	CbGeAlD
Drospirenone—PGR—vagina—polycystic ovary syndrome	0.00115	0.0129	CbGeAlD
Drospirenone—AR—uterus—polycystic ovary syndrome	0.00113	0.0127	CbGeAlD
Drospirenone—AR—pituitary gland—polycystic ovary syndrome	0.00111	0.0124	CbGeAlD
Drospirenone—AR—adipose tissue—polycystic ovary syndrome	0.0011	0.0124	CbGeAlD
Drospirenone—PGR—endocrine gland—polycystic ovary syndrome	0.00108	0.0121	CbGeAlD
Drospirenone—PTGS2—embryo—polycystic ovary syndrome	0.00105	0.0118	CbGeAlD
Drospirenone—BCHE—endometrium—polycystic ovary syndrome	0.000997	0.0112	CbGeAlD
Drospirenone—AR—adrenal gland—polycystic ovary syndrome	0.00099	0.0111	CbGeAlD
Drospirenone—AR—female gonad—polycystic ovary syndrome	0.000923	0.0104	CbGeAlD
Drospirenone—BCHE—uterus—polycystic ovary syndrome	0.000918	0.0103	CbGeAlD
Drospirenone—AR—vagina—polycystic ovary syndrome	0.000918	0.0103	CbGeAlD
Drospirenone—BCHE—pituitary gland—polycystic ovary syndrome	0.000902	0.0101	CbGeAlD
Drospirenone—BCHE—adipose tissue—polycystic ovary syndrome	0.000898	0.0101	CbGeAlD
Drospirenone—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00086	0.00964	CbGeAlD
Drospirenone—AR—endocrine gland—polycystic ovary syndrome	0.000859	0.00963	CbGeAlD
Drospirenone—Medroxyprogesterone Acetate—HSD3B2—polycystic ovary syndrome	0.000821	0.0997	CrCbGaD
Drospirenone—BCHE—adrenal gland—polycystic ovary syndrome	0.000806	0.00903	CbGeAlD
Drospirenone—PTGS2—endometrium—polycystic ovary syndrome	0.000768	0.00861	CbGeAlD
Drospirenone—BCHE—vagina—polycystic ovary syndrome	0.000747	0.00837	CbGeAlD
Drospirenone—PTGS2—uterus—polycystic ovary syndrome	0.000708	0.00793	CbGeAlD
Drospirenone—BCHE—endocrine gland—polycystic ovary syndrome	0.000699	0.00783	CbGeAlD
Drospirenone—PTGS2—pituitary gland—polycystic ovary syndrome	0.000695	0.00779	CbGeAlD
Drospirenone—PTGS2—adipose tissue—polycystic ovary syndrome	0.000692	0.00776	CbGeAlD
Drospirenone—PTGS2—adrenal gland—polycystic ovary syndrome	0.000621	0.00696	CbGeAlD
Drospirenone—PTGS2—female gonad—polycystic ovary syndrome	0.000579	0.00649	CbGeAlD
Drospirenone—PTGS2—vagina—polycystic ovary syndrome	0.000575	0.00645	CbGeAlD
Drospirenone—PTGS2—endocrine gland—polycystic ovary syndrome	0.000538	0.00603	CbGeAlD
Drospirenone—Medroxyprogesterone Acetate—AKR1C3—polycystic ovary syndrome	0.000455	0.0552	CrCbGaD
Drospirenone—Megestrol acetate—PGR—polycystic ovary syndrome	0.000434	0.0527	CrCbGaD
Drospirenone—Testosterone Propionate—CYP17A1—polycystic ovary syndrome	0.000429	0.0521	CrCbGaD
Drospirenone—Testolactone—CYP19A1—polycystic ovary syndrome	0.000401	0.0487	CrCbGaD
Drospirenone—Medrysone—NR3C1—polycystic ovary syndrome	0.000273	0.0331	CrCbGaD
Drospirenone—Spironolactone—PGR—polycystic ovary syndrome	0.00027	0.0328	CrCbGaD
Drospirenone—Flurandrenolide—NR3C1—polycystic ovary syndrome	0.000263	0.0319	CrCbGaD
Drospirenone—Testosterone Propionate—AR—polycystic ovary syndrome	0.000261	0.0316	CrCbGaD
Drospirenone—Medroxyprogesterone Acetate—PGR—polycystic ovary syndrome	0.000253	0.0307	CrCbGaD
Drospirenone—Spironolactone—SHBG—polycystic ovary syndrome	0.000252	0.0306	CrCbGaD
Drospirenone—Norethindrone—PGR—polycystic ovary syndrome	0.000251	0.0304	CrCbGaD
Drospirenone—Cortisone acetate—NR3C1—polycystic ovary syndrome	0.00025	0.0304	CrCbGaD
Drospirenone—Megestrol acetate—NR3C1—polycystic ovary syndrome	0.000241	0.0293	CrCbGaD
Drospirenone—Medroxyprogesterone Acetate—SHBG—polycystic ovary syndrome	0.000236	0.0287	CrCbGaD
Drospirenone—Norethindrone—SHBG—polycystic ovary syndrome	0.000234	0.0284	CrCbGaD
Drospirenone—Methyltestosterone—SHBG—polycystic ovary syndrome	0.000222	0.027	CrCbGaD
Drospirenone—Spironolactone—AR—polycystic ovary syndrome	0.000221	0.0269	CrCbGaD
Drospirenone—Medroxyprogesterone Acetate—AR—polycystic ovary syndrome	0.000207	0.0252	CrCbGaD
Drospirenone—Progesterone—CYP17A1—polycystic ovary syndrome	0.000197	0.0239	CrCbGaD
Drospirenone—Methyltestosterone—AR—polycystic ovary syndrome	0.000195	0.0237	CrCbGaD
Drospirenone—Testosterone—CYP11A1—polycystic ovary syndrome	0.000183	0.0222	CrCbGaD
Drospirenone—Hydrocortisone—SHBG—polycystic ovary syndrome	0.000167	0.0203	CrCbGaD
Drospirenone—Methyltestosterone—CYP19A1—polycystic ovary syndrome	0.000163	0.0198	CrCbGaD
Drospirenone—Spironolactone—NR3C1—polycystic ovary syndrome	0.00015	0.0182	CrCbGaD
Drospirenone—Progesterone—PGR—polycystic ovary syndrome	0.000146	0.0177	CrCbGaD
Drospirenone—Medroxyprogesterone Acetate—NR3C1—polycystic ovary syndrome	0.000141	0.0171	CrCbGaD
Drospirenone—Progesterone—SHBG—polycystic ovary syndrome	0.000136	0.0166	CrCbGaD
Drospirenone—Testosterone—SHBG—polycystic ovary syndrome	0.000129	0.0157	CrCbGaD
Drospirenone—PGR—Signaling by ERBB4—AKT2—polycystic ovary syndrome	0.000127	0.00145	CbGpPWpGaD
Drospirenone—AR—Gene Expression—LSM5—polycystic ovary syndrome	0.000126	0.00144	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000122	0.00139	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.00012	0.00138	CbGpPWpGaD
Drospirenone—Progesterone—AR—polycystic ovary syndrome	0.00012	0.0145	CrCbGaD
Drospirenone—AR—Gene Expression—SAP30L—polycystic ovary syndrome	0.000117	0.00134	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000117	0.00134	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000115	0.00132	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000115	0.00132	CbGpPWpGaD
Drospirenone—Testosterone—AR—polycystic ovary syndrome	0.000113	0.0137	CrCbGaD
Drospirenone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.000113	0.00129	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.000112	0.00128	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00011	0.00126	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00011	0.00126	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000108	0.00123	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.000106	0.00122	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	0.000105	0.0012	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—YAP1—polycystic ovary syndrome	0.000103	0.00117	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.0001	0.00115	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.0001	0.00115	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.0001	0.00114	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	9.98e-05	0.00114	CbGpPWpGaD
Drospirenone—AR—Gene Expression—TEAD2—polycystic ovary syndrome	9.97e-05	0.00114	CbGpPWpGaD
Drospirenone—Hydrocortisone—NR3C1—polycystic ovary syndrome	9.96e-05	0.0121	CrCbGaD
Drospirenone—AR—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	9.89e-05	0.00113	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—DLG4—polycystic ovary syndrome	9.74e-05	0.00111	CbGpPWpGaD
Drospirenone—Testosterone—CYP19A1—polycystic ovary syndrome	9.47e-05	0.0115	CrCbGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	9.43e-05	0.00108	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NPB—polycystic ovary syndrome	9.41e-05	0.00108	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	9.37e-05	0.00107	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—RPL37A—polycystic ovary syndrome	9.32e-05	0.00107	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	9.07e-05	0.00104	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—TNRC6B—polycystic ovary syndrome	9.06e-05	0.00104	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PGR—polycystic ovary syndrome	8.96e-05	0.00103	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NMNAT3—polycystic ovary syndrome	8.95e-05	0.00102	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	8.95e-05	0.00102	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	8.88e-05	0.00102	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—AR—polycystic ovary syndrome	8.82e-05	0.00101	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PGR—polycystic ovary syndrome	8.64e-05	0.000989	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	8.54e-05	0.000978	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.51e-05	0.000974	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	8.47e-05	0.000969	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	8.38e-05	0.00096	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	8.35e-05	0.000956	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	8.22e-05	0.000941	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—LPCAT2—polycystic ovary syndrome	8.19e-05	0.000937	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SUOX—polycystic ovary syndrome	8.19e-05	0.000937	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	8.17e-05	0.000935	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	8.16e-05	0.000934	CbGpPWpGaD
Drospirenone—Progesterone—NR3C1—polycystic ovary syndrome	8.11e-05	0.00986	CrCbGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	8.09e-05	0.000925	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	8.04e-05	0.00092	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	7.95e-05	0.00091	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.85e-05	0.000898	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.85e-05	0.000898	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	7.78e-05	0.000891	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	7.78e-05	0.00089	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	7.71e-05	0.000882	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ISYNA1—polycystic ovary syndrome	7.61e-05	0.000871	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	7.58e-05	0.000868	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	7.44e-05	0.000852	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—LHB—polycystic ovary syndrome	7.38e-05	0.000845	CbGpPWpGaD
Drospirenone—Progesterone—CYP1A1—polycystic ovary syndrome	7.37e-05	0.00895	CrCbGaD
Drospirenone—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	7.36e-05	0.000842	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.34e-05	0.00084	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	7.13e-05	0.000816	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.13e-05	0.000816	CbGpPWpGaD
Drospirenone—AR—Gene Expression—RPL37A—polycystic ovary syndrome	7.1e-05	0.000813	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	7.02e-05	0.000803	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AR—polycystic ovary syndrome	6.97e-05	0.000798	CbGpPWpGaD
Drospirenone—Testosterone—CYP1A1—polycystic ovary syndrome	6.97e-05	0.00846	CrCbGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	6.95e-05	0.000795	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.93e-05	0.000794	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—INHBB—polycystic ovary syndrome	6.76e-05	0.000773	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	6.62e-05	0.000758	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	6.6e-05	0.000755	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	6.59e-05	0.000754	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TEAD2—polycystic ovary syndrome	6.47e-05	0.000741	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKR1C2—polycystic ovary syndrome	6.47e-05	0.000741	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	6.45e-05	0.000738	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	6.34e-05	0.000725	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.31e-05	0.000722	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—YAP1—polycystic ovary syndrome	6.25e-05	0.000716	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	6.23e-05	0.000712	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	6.17e-05	0.000706	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	6.16e-05	0.000705	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	6.13e-05	0.000701	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NCOR1—polycystic ovary syndrome	6.09e-05	0.000697	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	5.88e-05	0.000673	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	5.87e-05	0.000672	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	5.75e-05	0.000658	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FSHR—polycystic ovary syndrome	5.75e-05	0.000658	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—IL6—polycystic ovary syndrome	5.72e-05	0.000655	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NR3C1—polycystic ovary syndrome	5.64e-05	0.000645	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	5.64e-05	0.000645	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	5.64e-05	0.000645	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	5.57e-05	0.000637	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	5.52e-05	0.000632	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—TNRC6B—polycystic ovary syndrome	5.51e-05	0.000631	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	5.47e-05	0.000626	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	5.43e-05	0.000622	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PNPLA2—polycystic ovary syndrome	5.43e-05	0.000621	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.4e-05	0.000618	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.25e-05	0.000601	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	5.25e-05	0.000601	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	5.24e-05	0.0006	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SRD5A1—polycystic ovary syndrome	5.14e-05	0.000589	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	5.12e-05	0.000586	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FST—polycystic ovary syndrome	5.12e-05	0.000586	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.06e-05	0.000579	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LHB—polycystic ovary syndrome	5e-05	0.000572	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	4.98e-05	0.00057	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—STAR—polycystic ovary syndrome	4.91e-05	0.000562	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.89e-05	0.000559	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	4.87e-05	0.000558	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.85e-05	0.000555	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	4.78e-05	0.000547	CbGpPWpGaD
Drospirenone—AR—Gene Expression—YAP1—polycystic ovary syndrome	4.76e-05	0.000545	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.73e-05	0.000542	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—ACE—polycystic ovary syndrome	4.72e-05	0.00054	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SCT—polycystic ovary syndrome	4.68e-05	0.000536	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	4.62e-05	0.000529	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	4.54e-05	0.000519	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	4.53e-05	0.000519	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.47e-05	0.000511	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	4.46e-05	0.00051	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	4.46e-05	0.00051	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF18—polycystic ovary syndrome	4.39e-05	0.000503	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HMMR—polycystic ovary syndrome	4.37e-05	0.000501	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PPARG—polycystic ovary syndrome	4.37e-05	0.0005	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RBP4—polycystic ovary syndrome	4.35e-05	0.000498	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	4.28e-05	0.00049	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	4.27e-05	0.000489	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AR—polycystic ovary syndrome	4.25e-05	0.000486	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	4.22e-05	0.000483	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	4.21e-05	0.000482	CbGpPWpGaD
Drospirenone—AR—Gene Expression—TNRC6B—polycystic ovary syndrome	4.2e-05	0.000481	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	4.17e-05	0.000477	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PGR—polycystic ovary syndrome	4.16e-05	0.000476	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.12e-05	0.000472	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—YAP1—polycystic ovary syndrome	4.07e-05	0.000465	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	4.03e-05	0.000462	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GAB1—polycystic ovary syndrome	4.01e-05	0.000459	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—SERPINE1—polycystic ovary syndrome	3.93e-05	0.00045	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.91e-05	0.000447	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	3.88e-05	0.000444	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—INSR—polycystic ovary syndrome	3.83e-05	0.000439	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—LHB—polycystic ovary syndrome	3.8e-05	0.000435	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	3.79e-05	0.000434	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPL37A—polycystic ovary syndrome	3.79e-05	0.000434	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	3.73e-05	0.000427	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	3.72e-05	0.000426	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NCOR1—polycystic ovary syndrome	3.71e-05	0.000425	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.64e-05	0.000417	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	3.6e-05	0.000412	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HMMR—polycystic ovary syndrome	3.59e-05	0.000411	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.59e-05	0.00041	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	3.54e-05	0.000405	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NR3C1—polycystic ovary syndrome	3.43e-05	0.000393	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—STAR—polycystic ovary syndrome	3.38e-05	0.000387	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.34e-05	0.000382	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	3.31e-05	0.000379	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GHRL—polycystic ovary syndrome	3.3e-05	0.000378	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PLAT—polycystic ovary syndrome	3.3e-05	0.000378	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—RRM2—polycystic ovary syndrome	3.21e-05	0.000367	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ATF1—polycystic ovary syndrome	3.15e-05	0.00036	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—YAP1—polycystic ovary syndrome	3.09e-05	0.000354	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.07e-05	0.000351	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	3.07e-05	0.000351	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	3.02e-05	0.000345	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	3.01e-05	0.000345	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	2.97e-05	0.00034	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	2.96e-05	0.000339	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.96e-05	0.000338	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	2.94e-05	0.000336	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	2.93e-05	0.000336	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.91e-05	0.000334	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NGFR—polycystic ovary syndrome	2.91e-05	0.000333	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRL—polycystic ovary syndrome	2.88e-05	0.00033	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	2.87e-05	0.000329	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.84e-05	0.000325	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NCOR1—polycystic ovary syndrome	2.83e-05	0.000324	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	2.77e-05	0.000317	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF18—polycystic ovary syndrome	2.75e-05	0.000314	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.73e-05	0.000313	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	2.73e-05	0.000312	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RBP4—polycystic ovary syndrome	2.72e-05	0.000312	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.69e-05	0.000308	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPARG—polycystic ovary syndrome	2.66e-05	0.000304	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LHB—polycystic ovary syndrome	2.62e-05	0.0003	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NR3C1—polycystic ovary syndrome	2.62e-05	0.000299	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	2.56e-05	0.000293	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GNAS—polycystic ovary syndrome	2.53e-05	0.00029	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	2.52e-05	0.000288	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GAB1—polycystic ovary syndrome	2.51e-05	0.000287	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	2.5e-05	0.000287	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	2.48e-05	0.000284	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NAMPT—polycystic ovary syndrome	2.44e-05	0.00028	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	2.42e-05	0.000277	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.41e-05	0.000276	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SERPINE1—polycystic ovary syndrome	2.4e-05	0.000274	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NRG1—polycystic ovary syndrome	2.37e-05	0.000271	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TH—polycystic ovary syndrome	2.36e-05	0.00027	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	2.3e-05	0.000263	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	2.28e-05	0.000261	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	2.28e-05	0.000261	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	2.24e-05	0.000257	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	2.21e-05	0.000253	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	2.16e-05	0.000247	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	2.13e-05	0.000244	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	2.05e-05	0.000234	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.03e-05	0.000233	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IRS2—polycystic ovary syndrome	2.03e-05	0.000232	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARG—polycystic ovary syndrome	2.03e-05	0.000232	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	2.02e-05	0.000231	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.01e-05	0.00023	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LEP—polycystic ovary syndrome	1.99e-05	0.000227	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GNAS—polycystic ovary syndrome	1.93e-05	0.000221	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	1.92e-05	0.00022	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	1.91e-05	0.000218	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	1.89e-05	0.000216	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	1.88e-05	0.000215	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	1.84e-05	0.00021	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SERPINE1—polycystic ovary syndrome	1.83e-05	0.000209	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRL—polycystic ovary syndrome	1.8e-05	0.000206	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IRS1—polycystic ovary syndrome	1.77e-05	0.000203	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	1.74e-05	0.000199	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—POMC—polycystic ovary syndrome	1.71e-05	0.000195	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—INS—polycystic ovary syndrome	1.7e-05	0.000194	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IGF1—polycystic ovary syndrome	1.64e-05	0.000188	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT2—polycystic ovary syndrome	1.64e-05	0.000188	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TH—polycystic ovary syndrome	1.63e-05	0.000186	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	1.62e-05	0.000186	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	1.58e-05	0.000181	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.56e-05	0.000178	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NCOR1—polycystic ovary syndrome	1.51e-05	0.000173	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	1.49e-05	0.00017	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NRG1—polycystic ovary syndrome	1.48e-05	0.00017	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTHFR—polycystic ovary syndrome	1.33e-05	0.000153	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	1.33e-05	0.000152	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARG—polycystic ovary syndrome	1.32e-05	0.000151	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—POMC—polycystic ovary syndrome	1.3e-05	0.000149	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—INS—polycystic ovary syndrome	1.29e-05	0.000148	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IRS2—polycystic ovary syndrome	1.27e-05	0.000145	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	1.26e-05	0.000145	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	1.2e-05	0.000137	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	1.12e-05	0.000128	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IRS1—polycystic ovary syndrome	1.11e-05	0.000127	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.07e-05	0.000123	CbGpPWpGaD
Drospirenone—PTGS2—Disease—INS—polycystic ovary syndrome	1.06e-05	0.000121	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT2—polycystic ovary syndrome	1.03e-05	0.000117	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	9.74e-06	0.000112	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	9.06e-06	0.000104	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—POMC—polycystic ovary syndrome	8.93e-06	0.000102	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—INS—polycystic ovary syndrome	8.88e-06	0.000102	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—polycystic ovary syndrome	7.41e-06	8.48e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—polycystic ovary syndrome	4.64e-06	5.31e-05	CbGpPWpGaD
